Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease.
作者信息
Sun Qi, Ye Fei, Liang Hao, Liu Hongbo, Li Chunmei, Lu Roujian, Huang Baoying, Zhao Li, Tan Wenjie, Lai Luhua
机构信息
BNLMS, Peking-Tsinghua Center for Life Sciences at College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, China CDC, Beijing, China.
出版信息
Signal Transduct Target Ther. 2021 May 29;6(1):212. doi: 10.1038/s41392-021-00628-x.
Abstract
摘要
Zotero 插件